Elotuzumab in Combination With Dose Reduced IMiDs and Dexamethasone for AL Amyloidosis Patients With Relapsed/Refractory Plasma Cell Dyscrasia and Advanced Organ Involvement.
| Title: | Elotuzumab in Combination With Dose Reduced IMiDs and Dexamethasone for AL Amyloidosis Patients With Relapsed/Refractory Plasma Cell Dyscrasia and Advanced Organ Involvement. |
|---|---|
| Authors: | Dittrich, Tobias; Hansen, Timon; Kimmich, Christoph R.; Veelken, Kaya; Jauch, Anna; Raab, Marc S.; Müller‐Tidow, Carsten; Hegenbart, Ute; Schönland, Stefan O. |
| Source: | American Journal of Hematology; Jun2025, Vol. 100 Issue 6, p1098-1101, 4p |
| Database: | Complementary Index |